Orgenesis Current Cash

Orgenesis (ORGS) currently reports a current cash of $200K as of September 2024. That compares with $55K in the prior-year period — up 270.9% year over year. Use the charts on this page to explore Orgenesis's current cash history and peer comparisons.

Orgenesis's current cash increased from $55K to $200K — a 270.9% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orgenesis reported $200K in current cash as of September 2024. That compares with $55K in the prior-year period — up 270.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $200K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orgenesis, and consider following ORGS for alerts when major investors trade the stock.

Orgenesis is classified in the Healthcare sector. On current cash, it currently shows $200K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORGS with unrelated industries.